Wells Fargo Maintains Overweight on Humana, Lowers Price Target to $413
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Stephen Baxter has maintained an Overweight rating on Humana (NYSE:HUM) but has reduced the price target from $465 to $413.
January 30, 2024 | 12:39 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Wells Fargo maintains an Overweight rating on Humana but lowers the price target from $465 to $413, indicating a potential downside compared to the previous target.
The reduction in price target by Wells Fargo suggests that they see less upside potential for Humana's stock price in the short term, which could lead to negative investor sentiment and a potential decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100